Satoru Sagae

Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)

Gordon John Sampson Rustin, Ignace Vergote, Elizabeth A. Eisenhauer et al. · International Journal of Gynecological Cancer · 2011 · 600 citations

2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)

Andreas du Bois, Michael Quinn, Tate Thigpen et al. · Annals of Oncology · 2005 · 465 citations

Medicine, Cancer Management, Reproductive Health +9

Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study

Nobuyuki Susumu, Satoru Sagae, Yasuhiro Udagawa et al. · Gynecologic Oncology · 2007 · 439 citations

Cisplatin-based Combined Chemotherapy, Gynecological Surgery, High-risk Endometrial Cancer +8

Distant metastases in epithelial ovarian carcinoma

J Dauplat, Neville F. Hacker, Roberta K. Nieberg et al. · Cancer · 1987 · 258 citations

Tumoral Pathology, Radiology, Median Survival +9

Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region.

Yasunobu Kanamori, Mieko Matsushima, Takeo Minaguchi et al. · PubMed · 1999 · 218 citations

Cancer Pathology, Gynecology, Pathology +17